In summary, using a mouse schwannoma model and VS from patients, we identify MMP9 as a highly active protease during schwannoma growth and in adherent VS, representing an excellent classifying biomarker to distinguish adherent from nonadherent tumors. This evidence concerns the gene MMP9 and schwannoma.